|
MYO19 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.965900E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.584300E-02 |
| Normal-vs-Stage2 |
8.920300E-02 |
| Normal-vs-Stage3 |
7.698400E-01 |
| Normal-vs-Stage4 |
2.633700E-02 |
| Stage1-vs-Stage2 |
3.456200E-01 |
| Stage1-vs-Stage3 |
1.090630E-01 |
| Stage1-vs-Stage4 |
4.122800E-01 |
| Stage2-vs-Stage3 |
1.163970E-01 |
| Stage2-vs-Stage4 |
6.843600E-01 |
| Stage3-vs-Stage4 |
4.349900E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.779180E-01 |
| Normal-vs-AfricanAmerican |
3.225800E-01 |
| Normal-vs-Asian |
5.625700E-02 |
| Caucasian-vs-AfricanAmerican |
7.041800E-01 |
| Caucasian-vs-Asian |
2.291800E-01 |
| AfricanAmerican-vs-Asian |
6.681000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.134580E-01 |
| Normal-vs-Female |
5.100000E-02 |
| Male-vs-Female |
8.770200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.794000E-02 |
| Normal-vs-Age(41-60Yrs) |
7.473400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.235580E-02 |
| Normal-vs-Age(81-100Yrs) |
5.179600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.198400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.319600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.429200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.489840E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.015400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.664000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.813000E-01 |
| Classical-VS-Follicular |
1.965630E-01 |
| Classical-VS-Other |
7.750000E-01 |
| Classical-VS-Normal |
7.025600E-02 |
| Tall-VS-Follicular |
2.300000E-01 |
| Tall-VS-Other |
8.163200E-01 |
| Tall-VS-Normal |
2.911000E-01 |
| Follicular-VS-Other |
2.137000E-01 |
| Follicular-VS-Normal |
3.633700E-02 |
| Other-VS-Normal |
6.873600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.490570E-01 |
| Normal-vs-N1 |
1.309650E-01 |
| N0-vs-N1 |
6.551000E-01 |
|
|
